%0 Journal Article
%T Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients
%A Jianhua Zhan
%A Jiaxing Huang
%A Li Zhang
%A Lin Liu
%A Nan Chen
%A Qing Liu
%A Shaodong Hong
%A Shiyang Kang
%A Tao Qin
%A Ting Zhou
%A Wenfeng Fang
%A Xiaobo He
%A Yan Huang
%A Yaxiong Zhang
%A Ying Chen
%A Yuanyuan Zhao
%A Yunpeng Yang
%A Yuxiang Ma
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2015.1094598
%K EML4-ALK
%K immunotherapy
%K NSCLC
%K PD-L1
%K PD-1
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839382/